Maintaining medicinal consistency across a global network requires navigating a labyrinth of geopolitical shifts and varying international regulatory expectations. The journey of a pharmaceutical product from a manufacturing plant to a patient’s local pharmacy is an intricate operation governed by
Sponsors of CNS-directed gene therapies are now being urged to embed independent imaging review boards directly into their trial protocols to avoid similar regulatory failures. This directive follows the U.S. Food and Drug Administration's decision to issue a second clinical hold on Regenxbio’s
This $1.3 million resolution follows a 2022 cybersecurity incident at the same organization, marking the second time in recent years that Central Maine Healthcare has faced a significant data exposure. The decision to settle represents a calculated move to mitigate the mounting legal risks and
Securing CE-MDR clearance has allowed SkyLabs to establish robust distribution networks in the United Kingdom and throughout mainland Europe's healthcare systems. This strategic milestone marks a significant step for the South Korean technology pioneer as it prepares for its transition to the
Pre-market evaluation is no longer a one-time approval but the start of a continuous monitoring process to prevent performance drift in GenAI-enabled medical equipment. Hospitals across the United States are witnessing a silent revolution where the stethoscope is being augmented by vast neural
The company reported a consolidated revenue of ₹4,031 crore for the first quarter of fiscal year 2027, reflecting a significant 12.89% annual growth. This financial achievement underscores the robust performance of its domestic portfolio, which continues to outpace the general Indian pharmaceutical
